Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1859 participants.

Also called NCT07258290

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,859 participants (planned count) (from the registry)
Sponsor
  • Teleflex Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07258290
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, France, Latvia, Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07258290. Randomized; single masking; primary purpose treatment. Start 2026-06-11 (actual); primary completion 2029-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Acronym
BIOMAG-III
Condition
Coronary Disease
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Condition
Arteriosclerosis
Condition
Arterial Occlusive Diseases
Condition
Vascular Diseases
Condition
Chest Pain
Condition
Pain
Condition
Neurologic Manifestations
Condition
Signs and Symptoms
Condition
Pathological Conditions, Signs and Symptoms
Condition
Myocardial Ischemia
Condition
Acute Coronary Syndrome
Condition
Angina Pectoris
Intervention (Device)
Freesolve RMS
Intervention (Device)
Xience DES
Lead sponsor
Teleflex (class: industry)

Record details

Record id
cardio:ct-nct07258290
Content hash
2cebe5f46b5480025e67123fe85d1f4ede870bfe38fe76b041649a33f52e95c3